MedTrace Logo

Days Alive and Out of Hospital for Patients With Sepsis

NCT04567433 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6213

Last updated 2024-02-23

No results posted yet for this study

Summary

We will perform a retrospective cohort study to assess the construct validity and performance of days alive and out of hospital at day 90 (DAOH90) in cohorts of patients with sepsis and septic shock who have been included in recent clinical trials.

Conditions

Interventions

DRUG

Hydroxyethyl starch

Hydroxyethyl starch compared to 0.9% saline

DRUG

Hydrocortisone

Hydrocortisone compared to Placebo

PROCEDURE

Early Goal Directed Therapy

Early Goal Directed Therapy compared to Usual Care

Sponsors & Collaborators

  • The George Institute for Global Health, Australia

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-14
Primary Completion
2024-02-23
Completion
2024-02-23

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04567433 on ClinicalTrials.gov